MHH-ES1 Cells
USD$395.00*
Products are shipped frozen on dry ice in cryotubes. Each cryotube typically contains 3 × 106 cells for adherent lines or 5 × 106 cells for suspension lines (refer to the batch CoA for details).
General information
| Description | The MHH-ES1 cell line is derived from a patient with Ewing sarcoma, a highly aggressive bone and soft tissue cancer predominantly affecting children and young adults. This cell line is a valuable model for studying the molecular mechanisms underlying Ewing sarcoma, particularly the role of the EWSR1-FLI1 fusion gene, which is characteristic of this cancer type. The fusion gene results from a translocation between chromosomes 11 and 22, leading to the production of an oncogenic transcription factor that drives tumorigenesis. MHH-ES1, like other Ewing sarcoma cell lines, is utilized to investigate the pathways influenced by EWSR1-FLI1, including alterations in cell proliferation, differentiation, and apoptosis. Researchers use the MHH-ES1 cell line to evaluate the efficacy of various therapeutic agents targeting pathways critical for Ewing sarcoma survival and proliferation. For example, it is instrumental in testing small molecule inhibitors, RNA interference, and CRISPR-Cas9 gene editing techniques aimed at disrupting the EWSR1-FLI1 fusion gene or its downstream effectors. Additionally, MHH-ES1 serves as a model to study resistance mechanisms to conventional chemotherapy and to identify novel biomarkers for early diagnosis and treatment response monitoring in Ewing sarcoma patients. |
|---|---|
| Organism | Human |
| Tissue | Bone |
| Disease | Ewing's Sarcoma |
| Metastatic site | Ascites |
| Synonyms | MHH-ES-1, MHHES1 |
Characteristics
| Age | 12 years |
|---|---|
| Gender | Male |
| Ethnicity | Turkish |
| Morphology | Small round cells |
| Growth properties | Adherent, clusters |
Regulatory Data
| Citation | MHH-ES1 (Cytion catalog number 300136) |
|---|---|
| Biosafety level | 1 |
| NCBI_TaxID | 9606 |
| CellosaurusAccession | CVCL_1411 |
Biomolecular Data
Handling
| Culture Medium | RPMI 1640, w: 2.0 mM stable Glutamine, w: 2.0 g/L NaHCO3 (Cytion article number 820700a) |
|---|---|
| Supplements | Supplement the medium with 10% FBS |
| Dissociation Reagent | Accutase |
| Subculturing | Remove the old medium from the adherent cells and wash them with PBS that lacks calcium and magnesium. For T25 flasks, use 3-5 ml of PBS, and for T75 flasks, use 5-10 ml. Then, cover the cells completely with Accutase, using 1-2 ml for T25 flasks and 2.5 ml for T75 flasks. Let the cells incubate at room temperature for 8-10 minutes to detach them. After incubation, gently mix the cells with 10 ml of medium to resuspend them, then centrifuge at 300xg for 3 minutes. Discard the supernatant, resuspend the cells in fresh medium, and transfer them into new flasks that already contain fresh medium. |
| Seeding density | 1 to 2 x 104 cells/cm2 |
| Fluid renewal | Every 3 to 5 days |
| Post-Thaw Recovery | After thawing, plate the cells at 5 x 104 cells/cm2 and allow the cells to recover from the freezing process and to adhere for at least 24 hours. |
| Freeze medium | As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress. |
| Thawing and Culturing Cells |
|
| Incubation Atmosphere | 37°C, 5% CO2, humidified atmosphere. |
| Shipping Conditions | Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage. |
| Storage Conditions | For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen. |
Quality Control & Molecular Analysis
| Sterility | Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods. To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections. |
|---|